Getting Started

Here we cover the basics on how the platform works. How to setup your community and everything in between. 

4 followers

1 question

154 posts

Malaria Treatment Market is expected to reach a valuation of US$ 2.93 billion by 2033 | FMI The Malaria Treatment Market is expected to be worth US$ 1.80 billion in 2023, up from US$ 1.72 billion in fiscal year 2022. From 2023 to 2033, the market is expected to grow at a 5% CAGR, reaching US$ 2.93 billion by the end of that year. According to the Globe Intellectual Property Organization (WIPO), more than 210 million people were affected by malaria in the world in 2019. Malaria is a contagious, sometimes lethal disease. It is caused by Plasmodium, a little parasite that mosquitoes transmit to humans. Malaria may be caused by four different plasmodium species; however, plasmodium falciparum is the one that most often results in fatal cases. Due to increased funding from regional governments, the global market for anti-malaria drugs is likewise growing rapidly. This money ought to make it feasible for research companies like Medicines for Malaria Venture to keep looking at potential lead chemicals that might combat malaria. For instance, in November 2017, the US Agency for International Development (USAID) gave US$ 9 million to Medicines for Malaria Venture to be used for three projects: a pharmacovigilance study of Pyramax (pyronaridine-artesunate), a SERC Phase III research to establish a single-exposure revolutionary cure, and a study to evaluate the efficacy of DSM265, a prospective single-exposure radical cure. These improvements are anticipated to drive the global market for malaria therapy. Get Full Access @ https://www.futuremarketinsights.com/reports/malaria-treatment-market Region-wise, the MEA will... (More)

IgA Nephropathy Market is expected to reach US$ 85 Billion by 2033 | FMI According to Future Market Insights, the IgA Nephropathy Market is expected to grow at a 7.5% CAGR between 2023 and 2033. By the year 2033, the global market for IgA nephropathy is expected to reach a value of US$ 85 billion. Key factors such as high prevalence of kidney diseases, the rising R&D activities, increasing investments by market players, and technological innovations are anticipated to significantly drive the market growth. Moreover, the growing number of initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests is a major factor likely to boost the market. Get Complete Access @ https://www.futuremarketinsights.com/reports/iga-nephropathy-market The COVID-19 pandemic has been associated with increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor and availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to temporary closure of other medical services. The diagnosis of several renal diseases deferred during the pandemic due to suspension of non-urgent visits and testing services. On the other hand, increasing awareness regarding IgA nephropathy is expected to create lucrative opportunities for the market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease. Major risk factors for... (More)

Encephalitis Treatment Market Future Scenario, Key Insights, Top Companies 2033 | FMI The global Encephalitis Treatment Market is currently valued at US$ 20.14 Billion in 2023 and is anticipated to expand at a CAGR of 5.4%. Owing to the technological advances in healthcare the market is likely to propel to US$ 34.08 Billion by 2033. The major factor attributing to the growth of the market is the high mortality and morbidity rate caused due to the incidence of encephalitis virus. Furthermore, increasing government initiatives for vaccination programs is boosting the market. As the number of cases and fatalities rises, individuals must take preventive measures such as immunisation, which increases demand for encephalitis treatment, thereby boosting the market growth. For more information: https://www.futuremarketinsights.com/reports/encephalitis-treatment-market The high disposable income, rising geriatric population, and changing lifestyles will result in the expansion of the encephalitis treatment market. Increasing research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate. The manufacturers are involved in the production of encephalitis treatment market in a larger capacity. Research and innovation are also conducted to launch innovative products for encephalitis treatment. North America dominates the encephalitis treatment market due to the presence of key market players' presence, along with recent product launches and established healthcare infrastructure, which will accelerate the market's growth in the region. The significant R&D investments in Europe abode well for market growth. Key Takeaways from the Market Study • As of 2023, the encephalitis treatment... (More)

Cardiovascular Ultrasound Market is expected to be worth US$ 2.6 billion by 2032 | FMI The Cardiovascular Ultrasound Market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as preventative medicine becomes more widely used and the prevalence of Cardiovascular Diseases (CVDs) rises. Outpatient imaging services were negatively impacted by the COVID-19 pandemic, which impeded global market growth. Get Complete Access: https://www.futuremarketinsights.com/reports/cardiovascular-ultrasound-market Coronary heart disease, heart attack, and stroke are among the most common causes of death in the United States. CVD predisposition has grown as a result of changing lifestyles. According to the CDC, 28.2 million persons in the United States were diagnosed with heart disease in 2017. Ultrasound technology is used to check for anomalies in the heart's function, such as cardiac pumping capacity, valve function, and plaque in the heart. Ultrasound imaging is a noninvasive medical diagnostic tool that helps doctors diagnose and treat medical issues. The images of the veins and arteries in the body are produced by vascular ultrasonography. A Doppler ultrasound scan is often part of a vascular ultrasound evaluation. They can also show blood flowing through arteries. The global cardiovascular ultrasound treatment market is being driven by factors such as the rising prevalence of heart diseases and the growing acceptability of cardiovascular... (More)